262 related articles for article (PubMed ID: 17599740)
1. Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment.
Peluso G; De Santis M; Inzitari R; Fanali C; Cabras T; Messana I; Castagnola M; Ferraccioli GF
Arthritis Rheum; 2007 Jul; 56(7):2216-22. PubMed ID: 17599740
[TBL] [Abstract][Full Text] [Related]
2. Different proteomic protein patterns in saliva of Sjögren's syndrome patients.
Fleissig Y; Deutsch O; Reichenberg E; Redlich M; Zaks B; Palmon A; Aframian DJ
Oral Dis; 2009 Jan; 15(1):61-8. PubMed ID: 18939961
[TBL] [Abstract][Full Text] [Related]
3. The minor salivary gland proteome in Sjögren's syndrome.
Hjelmervik TO; Jonsson R; Bolstad AI
Oral Dis; 2009 Jul; 15(5):342-53. PubMed ID: 19364392
[TBL] [Abstract][Full Text] [Related]
4. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome.
Laine M; Porola P; Udby L; Kjeldsen L; Cowland JB; Borregaard N; Hietanen J; Ståhle M; Pihakari A; Konttinen YT
Arthritis Rheum; 2007 Aug; 56(8):2575-84. PubMed ID: 17665393
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects.
Hjelmervik TO; Petersen K; Jonassen I; Jonsson R; Bolstad AI
Arthritis Rheum; 2005 May; 52(5):1534-44. PubMed ID: 15880807
[TBL] [Abstract][Full Text] [Related]
6. Presence of hepatitis C virus RNA in the salivary glands of patients with Sjögren's syndrome and hepatitis C virus infection.
Toussirot E; Le Huédé G; Mougin C; Balblanc JC; Bettinger D; Wendling D
J Rheumatol; 2002 Nov; 29(11):2382-5. PubMed ID: 12415596
[TBL] [Abstract][Full Text] [Related]
7. Comparison of salivary calmodulin binding proteins in Sjögren's syndrome and healthy individuals.
Deming FP; Al-Hashimi I; Haghighat N; Hallmon WW; Kerns DG; Abraham C; Rivera-Hidalgo F
J Oral Pathol Med; 2007 Mar; 36(3):132-5. PubMed ID: 17305633
[TBL] [Abstract][Full Text] [Related]
8. Salivary and serum interleukin 6 in primary Sjögren's syndrome.
Grisius MM; Bermudez DK; Fox PC
J Rheumatol; 1997 Jun; 24(6):1089-91. PubMed ID: 9195514
[TBL] [Abstract][Full Text] [Related]
9. Chemokine saliva levels in patients with primary Sjögren's syndrome, associated Sjögren's syndrome, pre-clinical Sjögren's syndrome and systemic autoimmune diseases.
Hernández-Molina G; Michel-Peregrina M; Hernández-Ramírez DF; Sánchez-Guerrero J; Llorente L
Rheumatology (Oxford); 2011 Jul; 50(7):1288-92. PubMed ID: 21330342
[TBL] [Abstract][Full Text] [Related]
10. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome.
Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M
J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253
[TBL] [Abstract][Full Text] [Related]
11. The effect of parotid salivary flow rate on the levels of salivary antimicrobial proteins in patients with Sjögren's syndrome.
Zipp MM; Yasbin L; al-Hashimi I
Quintessence Int; 1999 Oct; 30(10):700-5. PubMed ID: 10765854
[TBL] [Abstract][Full Text] [Related]
12. Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome?
Pers JO; d'Arbonneau F; Devauchelle-Pensec V; Saraux A; Pennec YL; Youinou P
Arthritis Rheum; 2005 Aug; 52(8):2411-4. PubMed ID: 16052575
[TBL] [Abstract][Full Text] [Related]
13. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjögren's syndrome.
Tapinos NI; Polihronis M; Thyphronitis G; Moutsopoulos HM
Arthritis Rheum; 2002 Jan; 46(1):215-22. PubMed ID: 11817594
[TBL] [Abstract][Full Text] [Related]
15. The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome.
Miceli-Richard C; Gestermann N; Ittah M; Comets E; Loiseau P; Puechal X; Hachulla E; Gottenberg JE; Lebon P; Becquemont L; Mariette X
Arthritis Rheum; 2009 Jul; 60(7):1991-7. PubMed ID: 19565491
[TBL] [Abstract][Full Text] [Related]
16. [Salivary immunoglobulins in the diagnosis of primary Sjögren's syndrome].
Bianucci GF; Campana G; Maddali Bongi S; Palermo C; Castagnoli A
Minerva Med; 1993 Apr; 84(4):161-70. PubMed ID: 8506054
[TBL] [Abstract][Full Text] [Related]
17. Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjögren's syndrome.
Ek M; Popovic K; Harris HE; Nauclér CS; Wahren-Herlenius M
Arthritis Rheum; 2006 Jul; 54(7):2289-94. PubMed ID: 16802368
[TBL] [Abstract][Full Text] [Related]
18. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
[TBL] [Abstract][Full Text] [Related]
19. The significance of salivary and serum interleukin 6 and basic fibroblast growth factor levels in patients with Sjögren's syndrome.
Boras VV; Cikes N; Lukac J; Cekić-Arambasin A; Virag M; Bosnjak A
Coll Antropol; 2004; 28 Suppl 2():305-9. PubMed ID: 15571105
[TBL] [Abstract][Full Text] [Related]
20. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
